Hence an approval in the next one-and-a-half to two years seems unlikely." Chereddi adds, "Hengrui's product is just starting Phase 3 in China, and Innovent's product has approval from the Chinese FDA, but hasn't been filed in India." His conclusion: "Indian generic manufacturers face a limited but real opportunitynot an open market." Shah frames it as a "timing risk, not an inevitability", and flags three gating factors beyond trial requirements: Regulatory scrutiny of novel oral delivery systems, bioavailability concerns specific to Indian populations and intellectual property protection on oral peptide platforms that limits immediate generic replication

Suppressing appetite through hormone pathways in the brain Slowing stomach emptying , which helps reduce calorie intake Improving insulin sensitivity and controlling post-meal glucose spikes Promoting fat loss while preserving lean muscle mass 3 Key Actions of Mounjaro Controls Blood Sugar Levels Stimulates insulin release when your blood sugar is high
As we begin to understand the nuances in ADC and tumor interactions, further refine in the design and chemistry of ADCs, development of strategies for patient selection, understanding of mechanisms of resistance and toxicity management are needed
You are not eating more
Zepbound decision came for me
Diabetes is a hard condition to manage